An increasing amount of data supports an inverse association between statin use and
cancer risk. The findings for prostate cancer, particularly advanced disease, are the most …

Despite key advances in the treatment of prostate cancer (PCa), a proportion of men have
de novo resistance, and all will develop resistance to current therapeutics over time …

Background. With the growth and aging of population, the incidence of prostate cancer will
increase year by year, which is bound to bring greater economic burden to the society …

The role of statin therapy in prostate cancer (PCa) prevention and treatment is plagued by
controversy. This critical review of published clinical series reveals several caveats in earlier …

Prostate cancer (PCa) is the most common malignant tumor of the male urological system
and poses a severe threat to the survival of middle‑aged and elderly males worldwide. The …

The role of statins in preventing prostate cancer is currently a controversial issue. The aim of
this review is to investigate the effects of statins use on prostate cancer risk. Electronic …

There have been several studies that have linked elevated scavenger receptor class b type
1 (SR-B1) expression and activity to the development and progression of castration-resistant …

Prostate cancer is one of the most common malignant tumors around the world.
Hyperlipidemia is considered as one of the most important risk factors for the development of …

Prostate cancer is the most prevalent malignancy in men. While diagn ostic and therapeutic
interventions have substantially improved in recent years, disease relapse, treatment …

Preclinical studies suggest statins may help prevent prostate cancer (PC), but epidemiologic
results are mixed. Many epidemiological studies have relatively short prediagnosis drug …